Author:
Fahlbusch R.,Giovanelli M.,Buchfelder M.,Losa M.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference29 articles.
1. Reubi J.C., Landolt A.M. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status. J. Clin. Endocrinol. Metab. 68: 844, 1989.
2. Spada A., Reza-Elahi F., Lania A., Gil del Alamo P., Bassetti M., Faglia G. Alterations in receptor status and postreceptor events in human pituitary tumors. In: Faglia G., Beck-Peccoz P., Ambrosi B., Travaglini P., Spada A. (Eds.), Pituitary adenomas: New trends in basic and clinical research. Excerpta Medica, Amsterdam, 1991, p. 95.
3. Schonbrunn A. Somatostatin action in pituitary cells involves two independent transduction mechanisms. Metabolism. 39 (Suppl. 2): 96, 1990.
4. Daughaday W.H., Starkey R.H., Saltman S., Gavin J.R. III, Mills-Dunlap B., Heath-Monnig E. Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH. J. Clin. Endocrinol. Metab. 65: 617, 1987.
5. Clemmons D.R., Van Wyk J.J., Ridgway E.C., Kliman B., Kjellberg R.N., Underwood L.E. Evaluation of acromegaly by radioimmunoassay of Somatomedin-C. N. Engl. J. Med. 301: 1138, 1977.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献